Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats

Journal of Nutritional Biochemistry

Volumn 22, Issue 3, 2011, Pages 282-288

  Peng, Hsiang Chi ^a   Chen, Ya Ling ^a   Chen, Jiun Rong ^a   Yang, Sien Sing ^b   Huang, Kuan Hsun ^a   Wu, Yi Chin ^a   Lin, Yun Ho ^c   Yang, Suh Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alcoholic liver disease; Glutamine; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 2E1; CYTOKINE; GLUTAMINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; INFLAMMATION; LIVER FUNCTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; CYTOCHROME P-450 CYP2E1; DIETARY SUPPLEMENTS; ETHANOL; GLUTAMINE; INFLAMMATION; INTERLEUKIN-1BETA; LIPID METABOLISM; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; RATTUS NORVEGICUS;

EID: 79951671381     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.02.006     Document Type: Article

References (43)

1. Das S.K., Vasudevan D.M. Alcohol-induced oxidative stress. Life Sci 2007, 81:177-187.
2. Duryee M.J., Klassen L.W., Thiele G.M. Immunological response in alcoholic liver disease. World J Gastroenterol 2007, 13:4938-4946.
3. Schaffert C.S., Duryee M.J., Hunter C.D., Hamilton B.C.r., DeVeney A.L., Huerter M.M., et al. Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol 2009, 15:1209-1218.
4. Lumeng L., Crabb D.W. Alcoholic liver disease. Curr Opin Gastroenterol 2001, 17:211-220.
5. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Thurman R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001, 34:101-108.
6. Yin M., Bradford B.U., Wheeler M.D., Uesugi T., Froh M., Goyert S.M., et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001, 166:4737-4742.
7. McClain C.J., Barve S., Deaciuc I., Kugelmas M., Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 1999, 19:205-219.
8. Fujimoto M., Uemura M., Nakatani Y., Tsujita S., Hoppo K., Tamagawa T., et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 2000, 24:48S-54S.
9. Cameron R.G., Neuman M.G. Novel morphologic findings in alcoholic liver disease. Clin Biochem 1999, 32:579-584.
10. Bode C., Bode J.C. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?. Alcohol Clin Exp Res 2005, 29:166S-171S.
11. Reeds P.J., Burrin D.G. Glutamine and the bowel. J Nutr 2001, 131:2505S-2508S. [discussion 23S-4S].
12. Wilmore D.W., Shabert J.K. Role of glutamine in immunologic responses. Nutrition 1998, 14:618-626.
13. Neu J., DeMarco V., Li N. Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 2002, 5:69-75.
14. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001, 16:398-402.
15. Tanaka T., Imano M., Yamashita T., Monna T., Nishiguchi S., Kuroki T., et al. Effect of combined alanine and glutamine administration on the inhibition of liver regeneration caused by long-term administration of alcohol. Alcohol Alcohol Suppl 1994, 29:125-132.
16. Cunningham C.C., Preedy V.R., Paice A.G., Hesketh J.E., Peters T.J., Patel V.B., et al. Ethanol and protein metabolism. Alcohol Clin Exp Res 2001, 25:262S-268S.
17. Basuroy S., Sheth P., Mansbach C.M., Rao R.K. Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and l-glutamine. Am J Physiol Gastrointest Liver Physiol 2005, 289:G367-G375.
18. Lieber C.S., DeCarli L.M. Animal models of chronic ethanol toxicity. Methods Enzymol 1994, 233:585-594.
19. Yeh S.L., Lai Y.N., Shang H.F., Lin M.T., Chen W.J. Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis. Br J Nutr 2004, 91:423-429.
20. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
21. Rudiger H.A., Clavien P.A. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002, 122:202-210.
22. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27:502-522.
23. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980, 106:207-212.
24. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
25. Yang S.C., Huang C.C., Chu J.S., Chen J.R. Effects of beta-carotene on cell viability and antioxidant status of hepatocytes from chronically ethanol-fed rats. Br J Nutr 2004, 92:209-215.
26. Pirola R.C., Lieber C.S. Energy wastage in rats given drugs that induce microsomal enzymes. J Nutr 1975, 105:1544-1548.
27. Morgan M.Y. The treatment of alcoholic hepatitis. Alcohol Alcohol 1996, 31:117-134.
28. Aguiar A.S., Boaventura G.T., Abrahao R.F., Freitas T.L., Takiya C.M., Filho P.J., et al. Ethanol in low chronic dose level attenuates major organic effects in malnourished rats. Biol Res 2009, 42:31-40.
29. Gordon H. Detection of alcoholic liver disease. World J Gastroenterol 2001, 7:297-302.
30. Lucey M.R., Mathurin P., Morgan T.R. Alcoholic hepatitis. N Engl J Med 2009, 360:2758-2769.
31. Sukhotnik I., Agam M., Shamir R., Shehadeh N., Lurie M., Coran A.G., et al. Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a rat. J Surg Res 2007, 143:379-384.
32. Margaritis V.G., Filos K.S., Michalaki M.A., Scopa C.D., Spiliopoulou I., Nikolopoulou V.N., et al. Effect of oral glutamine administration on bacterial tanslocation, endotoxemia, liver and ileal morphology, and apoptosis in rats with obstructive jaundice. World J Surg 2005, 29:1329-1334.
33. Komano T., Egashira Y., Sanada H. l-Gln and l-Ser suppress the d-galactosamine-induced IL-18 expression and hepatitis. Biochem Biophys Res Commun 2008, 372:688-690.
34. Lecleire S., Hassan A., Marion-Letellier R., Antonietti M., Savoye G., Bole-Feysot C., et al. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways. J Nutr 2008, 138:2481-2486.
35. Thurman R.G., Bradford B.U., Iimuro Y., Frankenberg M.V., Knecht K.T., Connor H.D., et al. Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front Biosci 1999, 4:e42-6.
36. Purohit V., Bode J.C., Bode C., Brenner D.A., Choudhry M.A., Hamilton F., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008, 42:349-361.
37. Li N., DeMarco V.G., West C.M., Neu J. Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells. J Nutr Biochem 2003, 14:401-408.
38. Purohit V., Gao B., Song B.J. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009, 33:191-205.
39. Hong F., Kim W.H., Tian Z., Jaruga B., Ishac E., Shen X., et al. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 2002, 21:32-43.
40. El-Assal O., Hong F., Kim W.H., Radaeva S., Gao B. IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol 2004, 1:205-211.
41. Singleton K.D., Beckey V.E., Wischmeyer P.E. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005, 24:583-589.
42. Wischmeyer P., John M. Kinney International Award for General Nutrition. Glutamine, heat shock protein, and inflammation - opportunity from the midst of difficulty. Nutrition 2004, 20:583-585.
43. Hong R.W., Rounds J.D., Helton W.S., Robinson M.K., Wilmore D.W. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 1992, 215:114-119.